Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Dinoprost tromethamine
Ceva Santé Animale
QG02AD01
Dinoprost tromethamine
12.5 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
dinoprost
Authorised
2020-12-04
Health Products Regulatory Authority 04 December 2020 CRN008DL3 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Enzaprost Bovis 12.5 mg/ml solution for injection for cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Dinoprost (as dinoprost trometamol) 12.5 mg EXCIPIENTS: Benzyl alcohol (E1519) 16.5 mg For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. Clear colourless to pale brownish yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (heifers and cows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is used in the following indications: - Induction of oestrus, - Controlled breeding in normally-cycling dairy cows: - oestrus synchronisation, - ovulation synchronisation in combination with GnRH or GnRH analogues as part of timed artificial insemination protocols. - Treatment of sub-oestrus or silent heat in cows which have a functional corpus luteum, - As supportive treatment of endometritis with the presence of functional corpus luteum and pyometra, - Induction of abortion, - Induction of parturition, including cases with complications such as hydrops amnii, etc, - Expulsion of mummified foetuses. 4.3 CONTRAINDICATIONS Do not use in animals suffering from either acute or sub-acute disorders of the vascular system, gastro-intestinal tract or respiratory system. Do not use in pregnant cows unless abortion or parturition is intended. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not administer by the intravenous route. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not administer more than 2 ml per single injection. The veterinary medicinal product is ineffective when administered prior to day 5 after ovulation in cattle. Health Products Regulatory Authority 04 December 2020 CRN008DL3 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in Leggi il documento completo